Hyaluronic acid-antigens conjugates trigger potent immune response in both prophylactic and therapeutic immunization in a melanoma model.

Malfanti, Alessio; Bausart, Mathilde; Vanvarenberg, Kevin; Ucakar, Bernard; Préat, Véronique

Malfanti, Alessio; Bausart, Mathilde; Vanvarenberg, Kevin; Ucakar, Bernard; Préat, Véronique.

Afiliação

Malfanti A; Advanced Drug Delivery and Biomaterials, UCLouvain, Louvain Drug Research Institute, Avenue Mounier 73 B1.73.12, 1200, Brussels, Belgium. alessio.malfanti@uclouvain.be.
Bausart M; Advanced Drug Delivery and Biomaterials, UCLouvain, Louvain Drug Research Institute, Avenue Mounier 73 B1.73.12, 1200, Brussels, Belgium.
Vanvarenberg K; Advanced Drug Delivery and Biomaterials, UCLouvain, Louvain Drug Research Institute, Avenue Mounier 73 B1.73.12, 1200, Brussels, Belgium.
Ucakar B; Advanced Drug Delivery and Biomaterials, UCLouvain, Louvain Drug Research Institute, Avenue Mounier 73 B1.73.12, 1200, Brussels, Belgium.
Préat V; Advanced Drug Delivery and Biomaterials, UCLouvain, Louvain Drug Research Institute, Avenue Mounier 73 B1.73.12, 1200, Brussels, Belgium. veronique.preat@uclouvain.be.

Drug Deliv Transl Res ; 13(10): 2550-2567, 2023 10.

Article em En | MEDLINE | ID: mdl-37040031

Assuntos

Ácido Hialurônico; Melanoma; Animais; Camundongos; Melanoma/tratamento farmacológico; Melanoma/prevenção & controle; Linfócitos T CD8-Positivos; Imunização; Imunidade; Microambiente Tumoral

Palavras-chave

Cancer vaccines; Hyaluronic acid; Immunotherapy; Melanoma; Polymer-drug conjugates

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Hialurônico / Melanoma Limite: Animals Idioma: En Revista: Drug Deliv Transl Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google